How Quickly Can the Effects of Excessive Caloric Intake on Insulin Resistance be Reversed?

July 25, 2022 updated by: Temple University
Objective: To show that a 1-2 day reduction of caloric intake can reduce the insulin resistance produced by several days of overnutrition. Approach: Healthy volunteers will be admitted to the Clinical Research Center and undergo a baseline euglycemic-hyperinsulinemic clamp study to assess their insulin resistance. Subjects will then start on an overnutrition program for 4 days consisting of 3 meals and 3 snacks containing ~6,000 Kcal/24hours. A second clamp study will be performed on day 5 to demonstrate the overnutrition induced increase in insulin resistance. Starting on day 5 the subject's caloric intake will be reduced to ~1,000 Kcal for 2 days (day 5 and 6). After that on the morning of day 7, a third hyperinsulinemic-euglycemic clamp will be performed to determine whether the reduced caloric intake did reduce insulin resistance and the volunteer will be discharged from the Clinical Research Center.

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

Study volunteers will be admitted to the Clinical Research Center at Temple University Hospital. After an overnight fast, body composition will be determined non-invasively by bioimpedance analysis (4) and a 4 h euglycemic-hyperinsulinemic clamp (using only FDA-approved regular insulin) as previously described (5) will be performed during which serum samples will be obtained for measurement of glucose, insulin, free fatty acids, ketone bodies and lipids. Oxidative stress ( 6) will be measured by 24 hour urine collections (analyzed for isoprostane content via 8-isoprostaglandin-F2alpha throughout the study period. Respiratory gas exchange rates (7) will be determined at hourly intervals (with a metabolic cart (True One, Parvo Utah) during the clamp studies and once a day on Days 2 through 6. After that, (at about 1:00 in the afternoon on Day 1) the volunteers will be started on a diet program for 4 ½ days, consisting of 3 meals and 3 snacks over a 24 hour period and containing ~ 6000 Kcal/24 h. The main meals (containing ~ 1500 Kcal/meal) will be served at ~ 8:00 in the morning (breakfast), 1:00 in the afternoon (lunch) and approximately 7:00 in the evening (dinner), the snacks (~ 500 Kcal/each) at approximately 11:00 in the morning, 4:00 in the afternoon and 11:00 in the night. On days 5 and 6, volunteers will receive 3 meals, each will contain ~333 calories. Each morning blood samples will be obtained to measure glucose insulin, free fatty acids and ketone bodies. Daily 24 h urine collections will be obtained each day. In the morning of Days 5 and 7, all procedures described for Day 1 will be repeated. In the afternoon of Day 7, the volunteers will be discharged from the hospital.

Study Type

Interventional

Enrollment (Actual)

1

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19140
        • Temple University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria: Healthy non-obese men and women -

Exclusion Criteria: Subjects with diabetes or a history of obesity surgery or with more than modest health problems

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: high caloric intake
Volunteers will receive 3 meals and 3 snacks over a 24 hour period which will contain ~ 6,000 calories. Main meals will consist of ~ 1,500 calories and snacks will contain ~ 500 calories.
Volunteers will be started on a diet program for 4 ½ days, consisting of 3 meals and 3 snacks over a 24 hour period and containing ~ 6000 Kcal/24 h.
Other: reduced caloric intake
On days 5 and 6 subjects will receive 3 meals only and each meal will contain ~ 333 calories for a total of 1,000/ 24 hours.
On days 5 and 6, volunteers will received 3 meals (~333 calories each) totaling ~ 1,000 calories/24 hours.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in insulin resistance
Time Frame: baseline, day 4 and day 7
Insulin resistance will be determined by measuring changes in insulin-stimulated total body glucose uptake during euglycemic hyperinsulinemic clamping
baseline, day 4 and day 7
Changes in oxidative stress
Time Frame: baseline, day1, day 2, day 3, day 4, day 5, day 6, day 7
24 hour urine collections analyzed for isoprostane content
baseline, day1, day 2, day 3, day 4, day 5, day 6, day 7
Changes in energy expenditure
Time Frame: baseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7
Changes in energy expenditure will be assessed with a metabolic cart (indirect calorimetry)
baseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7
Changes in weight
Time Frame: baseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7
Subjects will be weighed daily
baseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7
Changes in body composition
Time Frame: baseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7
Body composition will be determined by bioelectric impedance analysis
baseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in blood glucose levels
Time Frame: baseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7
Daily blood samples will be analyzed to determine glucose levels of glucose.
baseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7
Changes in blood levels of insulin
Time Frame: Baseline, day1 day2, day 3, day 4, day 5, day 6, day 7
Daily blood samples will be analyzed to determine insulin levels
Baseline, day1 day2, day 3, day 4, day 5, day 6, day 7
Changes in blood levels of free fatty acids
Time Frame: Baseline, day1 , day 2, day 3, day 4, day 5, day 6, day 7
Daily blood samples will be analyzed to determine free fatty acid levels
Baseline, day1 , day 2, day 3, day 4, day 5, day 6, day 7
Changes in blood ketone levels
Time Frame: baseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7
Daily blood samples will be analyzed to determine ketone levels
baseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7
Changes in glucagon levels
Time Frame: baseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7
Daily blood samples will be analyzed to determine glucagon levels
baseline, day 1, day 2, day 3, day 4, day 5, day 6, day 7

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ajaykumar Rao, MD, Temple University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2014

Primary Completion (Anticipated)

December 31, 2022

Study Completion (Anticipated)

December 31, 2023

Study Registration Dates

First Submitted

July 21, 2015

First Submitted That Met QC Criteria

July 21, 2015

First Posted (Estimate)

July 22, 2015

Study Record Updates

Last Update Posted (Actual)

July 28, 2022

Last Update Submitted That Met QC Criteria

July 25, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 22331
  • R01DK090588 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on high caloric intake

Subscribe